Arena Pharmaceuticals posts loss, but improv... Nov 10, 2009
Sequenom said third-quarter losses grew 43 percent to $14. 9 million, or 24 cents a share, as revenue dropped 21 percent to $9. (San Diego Union-Tribune)
Boston University scientists first to see RNA network in live bacterial cells Oct 23, 2009
Other study authors included Maria Valencia-Burton, research associate in biomedical engineering, Ankita Shah, undergraduate student, Jason Sutin, graduate student, Azra Borogovac, undergraduate student, and Charles Cantor, professor and director of biomedical engineering, all at Boston University, and Ron McCullough with Sequenom, Inc.. Founded in 1839, Boston University is an internationally recognized institution of higher education and research. (EurekAlert!)
Visa's New Goal Oct 10, 2009
Shaky Global Trading Shares fall ahead of the August consumer confidence figures in the U.S. NYSE Keeps Vonage After hours: Sequenom shares plunge; KBR lands overseas contract. Stocks Post Solid Gains Oil rises above $67 a barrel. (Forbes -- Business)
Rare Head And Neck Cancer Linked To HPV, Study Finds Oct 10, 2009
Disclosure: SensiGen is a wholly-owned subsidiary of Sequenom. The University of Michigan's Office of Technology Transfer has exclusively licensed HPV detection technology to Sequenom. (Science Daily)
10 Stocks Shaking the Market Jul 30, 2009
Sequenom (Nasdaq: SQNM) ... That much is certain in the aftermath of Sequenom's April revelation that certain employees had played fast and loose with R&D data and results ... For example, CAPS member TheHague is giving no quarter to Sequenom, because it failed a basic tenet of business: square dealing. (MSNBC -- Business)
Myriad Genetics, Oshkosh, Pfizer, Sequenom, Synnex: U.S. Equity Preview Jul 1, 2009
Myriad, Oshkosh, Pfizer, Sequenom, Synnex: U.S. Equity Preview - Bloomberg ... Myriad, Oshkosh, Pfizer, Sequenom, Synnex: U.S. Equity Preview. (Bloomberg -- US)
Pomerantz Reminds Sequenom, Inc. Investors of June 30 Deadline -- SQNM Jun 6, 2009
NEW YORK, June 5, 2009 (GLOBE NEWSWIRE) -- Investors in Sequenom, Inc. ("Sequenom" or the "Company") (Nasdaq: - ) have until June 30, 2009 to submit a request to be appointed Lead Plaintiff in the class action ... Sequenom is a diagnostic testing and genetics analysis company ... Defendants' public statements were false and/or failed to disclose material adverse information, i.e., (1) Sequenom employees "mishandled" test data and results regarding SEQureDx clinical trials; (2) SEQureDx did not... (Primezone Releases)
Transgenomic, Inc. Announces Appointment of New Board Members May 23, 2009
Before leading AviaraDx, Dr. Schuh was Chief Executive Officer of Arcturus Bioscience, Inc. and Sequenom, Inc.. Mr. McNulty is currently General Manager of Diagnostics at Agilent Technologies, Inc. Agilent Technologies Inc. is the world's premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. (PR Newswire)
Launch of prenatal test held pending fraud probe May 13, 2009
The company that developed the test, Sequenom Inc., was due to launch the test next month, but internal allegations that employees "mishandled data" led to the immediate suspension of four research and development employees, put the groundbreaking new product on hold and sent the company's stock plummeting ... "We don't believe the data from those tests was mishandled in any way but we obviously want to make sure that we don't make any assumptions there, that we actually send in new teams to... (Globe and Mail)
Scott+Scott LLP Files Class Action Lawsuit Against Sequenom, Inc. On Behalf of Investors -- SQNM May 12, 2009
NEW YORK, May 11, 2009 (GLOBE NEWSWIRE) -- On May 11, 2009, Scott+Scott LLP filed a class action complaint against Sequenom, Inc. (``Sequenom'' or the ``Company'') (NasdaqGM: - ) and certain officers and directors in the U.S. District Court for the Southern District of California. The action for violations of the Securities Exchange Act of 1934 is brought on behalf of those purchasing Sequenom common stock during the period beginning June 4, 2008 through April 29, 2009, inclusive (the ``Class... (Primezone Releases)
Shareholder Class Action Filed Against Sequenom, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP May 9, 2009
Shareholder Class Action Filed Against Sequenom, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer , LLP ... Shareholder Class Action Filed Against Sequenom, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer , LLP ... Notice is hereby given that a class action lawsuit was filed in the United States District Court for the Southern District of California on behalf of purchasers of the securities of Sequenom, Inc. (Nasdaq: ) ("Sequenom" or the "Company") between June 4, 2008 and April 29,... (PR Newswire)
The Pomerantz Firm Charges Sequenom, Inc. With Securities Fraud -- SQNM May 8, 2009
NEW YORK, May 7, 2009 (GLOBE NEWSWIRE) -- Pomerantz Haudek Grossman & Gross LLP () (``Pomerantz'') has filed a class action lawsuit in the United States District Court, Southern District of California, against Sequenom, Inc. (``Sequenom'' or the ``Company'') (NasdaqGM: - ) and certain of its top officials ... Sequenom is a diagnostic testing and genetics analysis company ... Defendants' public statements were false and/or failed to disclose material adverse information, i.e., (1) Sequenom... (Primezone Releases)
Faruqi & Faruqi, LLP Announces Class Action Lawsuit Filed Against Sequenom, Inc. -- SQNM May 6, 2009
Faruqi i, LLP Announces Class Action Lawsuit Filed Against Sequenom, Inc. -- SQNM - Yahoo ... Faruqi i, LLP Announces Class Action Lawsuit Filed Against Sequenom, Inc. -- SQNM ... LOS ANGELES, May 5, 2009 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a law firm with extensive experience in prosecuting claims for securities fraud, has filed a lawsuit on behalf of a class of shareholders who purchased or otherwise acquired the securities of Sequenom, Inc. (``Sequenom'' or the ``Company'') (NasdaqGM: -... (Primezone Releases)
The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Sequenom, Inc. May 2, 2009
NEW YORK, May 1, 2009 (GLOBE NEWSWIRE) -- The Brualdi Law Firm, P.C. announces that a lawsuit has been commenced in the United States District Court for the Southern District of California on behalf of purchasers of Sequenom, Inc. (``Sequenom'') (NasdaqGM: - ) common stock during the period between June 4, 2008 and April 29, 2009 (the ``Class Period'') for violations of the federal securities laws ... If you purchased Sequenom common stock during the Class Period, and wish to move the court for... (Primezone Releases)
First Solar, Green Mountain, JDS Uniphase, Sequenom: U.S. Equity Preview Apr 30, 2009
First Solar, Green Mountain, JDS, Sequenom: U.S. Equity Preview - Bloomberg ... First Solar, Green Mountain, JDS, Sequenom: U.S. Equity Preview. (Bloomberg -- US)
Now Is a Fantastic Time to Be a Momentum Investor Mar 16, 2009
Surely you know some of them: Sequenom (Nasdaq: SQNM), Hot Topic (Nasdaq: HOTT), and Amgen (Nasdaq: AMGN), to name three. The limits of business momentumHigher guidance isn't always a perfect indicator of rising prices, of course. (MSNBC -- Business)
Hundreds of new corporate facilities, expansions earn Michigan No. 3 spot in global publication Mar 13, 2009
Major expansion projects announced in 2008 include: Marathon Oil in Detroit, North American Bancard in Troy, General Dynamics Land Systems in Sterling Heights, Brose Jefferson in Warren, United Solar Ovonic in Battle Creek, Sequenom in Grand Rapids, Hemlock Semiconductor in Thomas Township and Consolidated Biscuit in Tecumseh. Granholm pointed to the comprehensive steps Michigan has taken to grow the economy and compete for new jobs and investment, including. (Dowagiac News, MI)
Paragon Medsystems Becomes California MedTech Feb 17, 2009
Cal MedTech has developed medical electronics and lab instruments for high-profile medtech companies throughout California, including NuVasive, Ablation Frontiers, Zoll Medical, Peak Surgical, Sequenom, and Becton-Dickinson, as well as firms outside California including Boston Scientific and Smith & Nephew, according to Kelleher. "Our R&D team includes some of the most experienced medtech engineers in the industry," he states, adding "we also leverage our MedBlox(TM) family of subsystems, so we... (PR Newswire)
Simple test, complex questions Feb 8, 2009
Sequenom Inc., a biotech firm based in San Diego, says it will begin selling the first non-invasive prenatal genetic test, pioneered at the University of Oxford, online in June ... Sequenom licensed the Oxford technology in 2005 and says it will likely sell the test for roughly $700 (U.S.) ... Sequenom has so far tried its test in 399 pregnant women and found it has an accuracy rate of 99. (Globe and Mail -- National)
Adult Stem Cells Convert Into Embryonic-like Stem Cells, With Single Factor Feb 7, 2009
The researchers include Jeong Beom Kim, Max Planck Institute for Molecular Biomedicine, Munster, Germany; Vittorio Sebastiano, Max Planck Institute for Molecular Biomedicine, Munster, Germany; Guangming Wu, Max Planck Institute for Molecular Biomedicine, Munster, Germany; Marcos J. Arauzo-Bravo, Max Planck Institute for Molecular Biomedicine, Munster, Germany; Philipp Sasse, University of Bonn, Bonn, Germany; Luca Gentile, Max Planck Institute for Molecular Biomedicine, Munster, Germany; Kinarm... (Science Daily)
News Scan Briefs: Weak on the Nano Risk Feb 7, 2009
The San Diego based biotech company Sequenom plans to develop the test for commercial distribution. The study appears in the December 16, 2008, Proceedings of the National Academy of Sciences USA. Gary Stix. (Scientific American)
